Our group evaluated whether the dose of infused CD34 stem cells correlated with ALC-15 and no correlation was identified in lymphoma patients (Spearman’s rho, r = 0.11, p = 0.8) or in multiple myeloma patients (Spearman’s rho, r = 0.27, p = 0.67) [18,19]. Here, CD34 is linked to lymphoma.